Loading...

ELISA MAX™ Deluxe Set Mouse TNF-α

Pricing & Availability
Regulatory Status
RUO
Other Names
TNF-a ELISA Kit
Ave. Rating
Submit a Review
Product Citations
publications
mouse tnf-a_122109
  • mouse tnf-a_122109
Cat # Size Price Quantity Check Availability Save
430904 5 plates 305 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430915 10 Plates 586 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430916 20 Plates 938 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

ELISA Development Systems Engineered for Sensitive, Precise and Reliable Serum and Plasma Cytokine Quantitation

BioLegend's ELISA Max™ Sets provide all the time-savings, convenience and performance of a high-end, commercial ELISA kit for a fraction of the price!

BioLegend's ELISA Max™ Sets, in two appealing formats, address the need for sensitivity, accuracy, dependability, and versatility of an ELISA development system, while providing maximum cost effectiveness, value, and ease of use.

Both the ELISA Max™ Set Standard and ELISA Max™ Set Deluxe are specifically engineered for accurate recovery and measurement of analytes in complex fluids, such as serum and plasma (as well as activated cell cultures) without any interference by confounding serum factors, such as heterophilic antibody or rheumatoid factor.

Product Details
Technical Data Sheet (pdf)

Kit Contents

Kit Contents
  • Mouse TNF-α ELISA MAX™ Capture Antibody (200X)
  • Mouse TNF-α ELISA MAX™ Detection Antibody (200X)
  • Mouse TNF-α Standard
  • Avidin-HRP (1000X)
  • Substrate Solution A
  • Substrate Solution B
  • Coating Buffer A (5X)
  • Assay Diluent A (5X)

Product Details

Verified Reactivity
Mouse
Application

ELISA
 
As a part of BioLegend's efforts to go green, each new lot of the ELISA MAX™ sets will include a summarized version of its manual. Click here for more information.
Application References

(PubMed link indicates BioLegend citation)
  1. Patole PS, et al. 2005. J. Am. Soc. Nephrol. 16:3273.
  2. ChavantF, et al. 2010. J. Pharmacol Exp. Ther. 332:505. PubMed
  3. Lewis CJ, et al. 2010. J. Immunol. 184:3789. PubMed
  4. Qui J, et al. Appl Environ Microbiol. PubMed
  5. Yang HJ, et al. 2011. J Cell Sci. 124:2552. PubMed.
  6. White LE, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 303:449. PubMed
  7. Zhang X, et al. 2014. PLoS One. 9:90856. PubMed
  8. Zachman AL, et al. 2014. Biomaterials. 35:9635. PubMed
  9. Goldberg R, et al. 2014. Diabetes. 63:4302. PubMed
  10. Zahman AL, et al. 2014. Biomaterials. 35:9635. PubMed
  11. Justice JN, et al. 2015. J appl Physiol. 118:163. PubMed
Product Citations
  1. Luo W, et al. 2018. Bioorg Med Chem. 26:1547. PubMed
  2. Dong X, et al. 2019. ACS Nano. 13:1272. PubMed
  3. Guo W, et al. 2021. Int J Biol Sci. 17:4271. PubMed
  4. Chou WC, et al. 2021. Nature. 591:300. PubMed
  5. Ishikawa S, et al. 2021. Biol Pharm Bull. 44:550. PubMed
  6. Cerrato G, et al. 2021. Cell Death Differ. 28:1733. PubMed
  7. Shih S, et al. 2016. PLoS One. 11: 0157647. PubMed
  8. Kim MW, et al. 2020. Front Bioeng Biotechnol. 8:133. PubMed
  9. Li DY, et al. 2018. Sci Rep. 8:17979. PubMed
  10. Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed
  11. Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed
  12. Nagata K, et al. 2020. Int Immunol. 32:143. PubMed
  13. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  14. Yang Y, et al. 2020. J Int Med Res. 48:300060520902605. PubMed
  15. Ma X, et al. 2022. Cell Mol Immunol. . PubMed
  16. Kalafatakis I, et al. 2021. J Neurosci Res. 99:1474. PubMed
  17. Zachman A, et al. 2014. Biomaterials. 35:9635. PubMed
  18. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  19. Naji A, et al. 2016. Sci Rep. 6: 26162. PubMed
  20. Sun T, et al. 2018. Front Immunol. 9:1245. PubMed
  21. Li H, et al. 2021. Mol Med Rep. 1:23. PubMed
  22. Clausen B, et al. 2016. Sci Rep. 6:29291. PubMed
  23. Zhang B, et al. 2021. Exp Ther Med. 22:832. PubMed
  24. Lv ZY, et al. 2022. J Inflamm Res. 15:2819. PubMed
  25. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  26. Ye H, et al. 2016. Exp Mol Pathol. 100: 307-311. PubMed
  27. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  28. Liu X, et al. 2021. Int J Mol Sci. 22:. PubMed
  29. Ahangar P, et al. 2020. NPJ Regen Med. 24:5. PubMed
  30. Brunetti J, et al. 2016. J Biol Chem. 291(49):25742-25748. PubMed
  31. Yang H, et al. 2011. J Cell Sci. 124:2552. PubMed
  32. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  33. Schaafsma W, et al. 2017. Neurobiology of Disease. 10.1016/j.nbd.2017.07.017. PubMed
  34. Shaker ME, et al. 2022. Saudi Pharm J. 30:291. PubMed
  35. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  36. Park GT, et al. 2021. Mar Drugs. 19:. PubMed
  37. Lin CC, et al. 2021. Iran J Basic Med Sci. 24:1146. PubMed
  38. Li Y, et al. 2021. J Neurochem. 159:867. PubMed
  39. Zhang X, et al. 2014. PLoS One. 9:90856. PubMed
  40. Qiu J, et al. 2010. Appl Envir Microbiol. 76:5846. PubMed
  41. Dai X, et al. 2017. FASEB J. 31:2881. PubMed
  42. Liu R, et al. 2018. Exp Ther Med. 15:3385. PubMed
  43. Sousa AH, et al. 2021. Can J Physiol Pharmacol. 99:1324. PubMed
  44. Hsu CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  45. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  46. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  47. Iannucci J, et al. 2020. Cell Mol Neurobiol. . PubMed
  48. Liu TH, et al. 2018. Nutrients. 10:E472. PubMed
  49. Medrano–Jiménez E, et al. 2019. J Neuroinflammation. 16:143. PubMed
  50. Park GT, et al. 2019. Front Immunol. 10:2095. PubMed
  51. Yu Y, et al. 2021. Cell Rep. 37:110126. PubMed
  52. Wang J, et al. 2022. J Clin Invest. :. PubMed
  53. Lee N, et al. 2022. Front Immunol. 13:940258. PubMed
  54. Hsueh SC, et al. 2022. Biomedicines. 10:. PubMed
  55. Al Mamun A, et al. 2020. Proc Natl Acad Sci U S A. 117:1742. PubMed
  56. Ci T, et al. 2020. Sci Adv. 6:00. PubMed
  57. Wilson JL, et al. 2020. Cell Rep. 30:1542. PubMed
  58. Xiahou Z,et al. 2017. Nat Commun. . 10.1038/s41467-017-00930-9. PubMed
  59. Qi S, et al. 2022. Transl Stroke Res. :. PubMed
  60. Hsu CG, et al. 2021. J Immunol. 206:3010. PubMed
  61. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  62. Zhou XM, et al. 2018. Front Pharmacol. 8:904. PubMed
  63. Sun B, et al. 2018. Cell Mol Immunol. 1.168055556. PubMed
  64. Li WS, et al. 2021. Int J Mol Sci. 22:. PubMed
  65. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  66. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  67. Wang C, et al. 2020. Redox Biol. 37:101688. PubMed
  68. White L, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 303:449. PubMed
  69. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  70. Justice J, et al. 2015. J Appl Physiol. 118:163. PubMed
  71. Chan K, et al. 2015. J Biol Chem. 290: 16979 - 16988. PubMed
  72. Stanfield BA, et al. 2021. PLoS One. 16:e0245169. PubMed
  73. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  74. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  75. Yang FM, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  76. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  77. Scanu A, et al. 2022. Int J Mol Sci. 23:. PubMed
  78. Deng LR, et al. 2022. Chin Med. 17:132. PubMed
  79. Schaafsma W, et al. 2015. Brain Behav Immun. 48: 205-221. PubMed
  80. Nagata K, et al. 2021. Front Immunol. 12:730706. PubMed
  81. Gu H, et al. 2021. Elife. 10:. PubMed
  82. Zhuo X, et al. 2021. Biomed Rep. 15:64. PubMed
  83. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  84. de León-Guerrero SD, et al. 2022. Dis Model Mech. . PubMed
  85. Su S, et al. 2022. Signal Transduct Target Ther. 7:137. PubMed
  86. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  87. Goldberg R, et al. 2014. Diabetes. 63:4302. PubMed
  88. Li X, et al. 2022. Sci Rep. 12:17058. PubMed
  89. Agrahari G, et al. 2021. Front Immunol. 12:628117. PubMed
  90. Cobb C 2010. J Immunol. 184:3789. PubMed
  91. Chavant F, et al. 2010. J Pharmacol Exp Ther. 332:505. PubMed
  92. Reed MD, et al. 2020. Nature. 577:249. PubMed
  93. Fante T, et al. 2016. PLoS One. 11: 0160184. PubMed
  94. Chen Y, et al. 2018. Exp Ther Med. 16:4322. PubMed
  95. Ratna A, et al. 2021. Hepatol Commun. 5:1165. PubMed
Sensitivity
4 pg/mL
Standard Range
7.8-500 pg/mL
Materials Not Included
  • Microwell plates: 96-well Nunc MaxiSorp™ is recommended.
  • A microplate reader capable of measuring absorbance at 450 nm
  • Adjustable pipettes to measure volumes ranging from 2 µL to 1 mL
  • Deionized (DI) water
  • PBS (Phosphate-Buffered Saline): 8.0 g NaCl, 1.16 g Na2HPO4, 0.2 g KH2PO4, 0.2 g KCl, add deionized water to 1 L; pH to 7.4, 0.2 µm filtered.
  • Wash Buffer (Phosphate-Buffered Saline (PBS) + 0.05% Tween-20, pH=7.4). BioLegend Cat. No. 421601 is recommended.
  • Wash bottle or automated microplate washer
  • Stop Solution (e.g. 2N H2SO4) Biolegend Cat. No. 423001 is recommended
  • Log-Log graph paper or software for data analysis
  • Tubes to prepare standard dilutions
  • Timer
  • Plate Sealer
  • Absorbent paper

Antigen Details

Cell Sources
Activated monocytes, neutrophils, macrophages, T cells, B cells, NK cells, LAK cells
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Gene ID
21926 View all products for this Gene ID
UniProt
View information about TNF-alpha on UniProt.org

Related FAQs

Do the ELISA MAX™ Deluxe Sets come with plates?

No, ELISA MAX™ Deluxe Sets do not come with plates. Coating Buffer and Assay Diluent (for blocking and dilutions) are included in these sets. Plates can be ordered separately (Cat No. 423501), and instructions for coating the plates are in the sets’ product manuals.

Go To Top Version: 4    Revision Date: 12.14.2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account